Kit, Disc, Agar Gel Diffusion, Determine Serum Levels Of Tobramycin

FDA classification

FDA Class 2 ·Kit, Disc, Agar Gel Diffusion, Determine Serum Levels Of Tobramycin

Kit, Disc, Agar Gel Diffusion, Determine Serum Levels Of Gentamicin

FDA classification

FDA Class 2 ·Kit, Disc, Agar Gel Diffusion, Determine Serum Levels Of Gentamicin

Kit, Disc, Agar Gel Diffusion, Determine Serum Levels Of Kanamycin

FDA classification

FDA Class 2 ·Kit, Disc, Agar Gel Diffusion, Determine Serum Levels Of Kanamycin

Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletion

FDA classification

FDA Class 3 ·Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletion

Nucleic Acid Amplification, Novel Influenza A Virus, A/H5 (Asian Lineage) Rna

FDA classification

FDA Class 2 ·Nucleic Acid Amplification, Novel Influenza A Virus, A/H5 (Asian Lineage) Rna

Phototherapy Device For Reducing The Appearance Of Acute Post-Surgical Incisions

FDA classification

FDA Class 2 ·Phototherapy Device For Reducing The Appearance Of Acute Post-Surgical Incisions

System, Mass Spectrometry, Multiplex Genotyping, Hereditary Thrombophilia Related Mutations

FDA classification

FDA Class 2 ·System, Mass Spectrometry, Multiplex Genotyping, Hereditary Thrombophilia Related Mutations

Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System

FDA classification

FDA Class 2 ·Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System

Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System

FDA classification

FDA Class 3 ·Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System

Early Growth Response Gene 1 (Egr1) Fish Probe Kit For Specimen Characterization

FDA classification

FDA Class 2 ·Early Growth Response Gene 1 (Egr1) Fish Probe Kit For Specimen Characterization

Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

FDA classification

FDA Class 3 ·Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

Next Generation Sequencing Based Tumor Profiling Test

FDA classification

FDA Class 2 ·Next Generation Sequencing Based Tumor Profiling Test

Fluorescence In Situ Hybridization, Platelet-Derived Growth Factor Receptor, Beta Polypeptide (Pdgfrb), Rearrangement

FDA classification

FDA Class 3 ·Fluorescence In Situ Hybridization, Platelet-Derived Growth Factor Receptor, Beta Polypeptide (Pdgfrb), Rearrangement

External Urethral Occluder, Urinary Incontinence-Control, Female

FDA classification

FDA Class 1 ·External Urethral Occluder, Urinary Incontinence-Control, Female

Respiratory Panel

FDA classification

FDA Class 2 ·Respiratory Panel

Spinal Muscular Atrophy Newborn Screening Test System

FDA classification

FDA Class 2 ·Spinal Muscular Atrophy Newborn Screening Test System

Serpina1 Variant Detection System

FDA classification

FDA Class 2 ·Serpina1 Variant Detection System

High Throughput Sequencing Based Tumor Profiling Test Of Circulating Cell-Free Nucleic Acids

FDA classification

FDA Class 2 ·High Throughput Sequencing Based Tumor Profiling Test Of Circulating Cell-Free Nucleic Acids

High Throughput Dna Sequencing For Hereditary Cancer Predisposition Assessment Test System.

FDA classification

FDA Class 2 ·High Throughput Dna Sequencing For Hereditary Cancer Predisposition Assessment Test System.

Cancer Predisposition Risk Assessment System

FDA classification

FDA Class 2 ·Cancer Predisposition Risk Assessment System